Related references
Note: Only part of the references are listed.Ophthalmic follow-up of patients with tyrosinaemia type I on NTBC
P Gissen et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2003)
Corneal opacities associated with NTBC treatment
S Ahmad et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Pharmacokinetics and pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-1,3-cyclohexanedione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers
MG Hall et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) and its effect on enzymes involved in tyrosine catabolism in the mouse
EA Lock et al.
TOXICOLOGY (2000)
Share Paper
